Zhongping Yang,Thomas A. Anderson,Brian P. Colin,William J. Clemens,Subham Ghosh,Jeffrey M. Gillberg,Maurice T. I. Verbeek,Toine Camps,Lilian Kornet,Berthold Stegemann,Jean Rutten
申请号：
US16361970
公开号：
US20190290910A1
申请日:
2019.03.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.
